Cognyte Software Ltd.
Cognyte Software Ltd. sells investigative analytics software platforms and solutions to government agencies and commercial security enterprises via direct sales and enterprise partnerships by providing advanced analytics tools for investigations, integration services, and customer support.
LOCKED
Market: NormalKey Catalysts & Risks
The company's entry into the US public sector through a July 2024 partnership with Four Inc. serves as a major potential growth wedge, enabling access to massive federal contract vehicles like NASA SEWP and GSA. Continued operating leverage is a key upside driver, with FY26 guidance projecting Adjusted EBITDA growth (~55%) significantly outpacing revenue growth (~13%), which could drive multiple expansion if executed. Conversely, any delay in closing large, lumpy government deals or renewed regulatory scrutiny on the surveillance sector could compress valuation.
Cognyte faces structural ESG and reputational risks due to the nature of its surveillance technology, highlighted by its exclusion from the Norwegian Government Pension Fund Global due to human rights concerns. While the company positions itself as an analytics provider rather than a 'spyware' vendor, it operates in a sector subject to intense scrutiny from privacy regulators and tech platforms (e.g., past Meta bans), which could permanently restrict its addressable market in Western democracies.
Research refreshed: 23rd of November 2025
KPIs and Peer Benchmarks
| EV | P/E | Net Debt/EBIT | Revenue Growth | |
|---|---|---|---|---|
| BigBear.ai … (BBAI) | 1.24B | N.M. | N.M. | -19.3% |
| Cellebrite … (CLBT) | 2.66B | 47.32 | -2.09 | 18.6% |
| Elbit Syste… (ESLT) | 34.3B | 52.09 | 0.75 | 16.3% |
| Open Text C… (OTEX) | 10.4B | 4.94 | 2.61 | 1.5% |
| Palantir Te… (PLTR) | 431B | 149.73 | -0.69 | 56.2% |
| Cognyte Sof… (CGNT) | 581M | N.M. | -3.84 | 14.1% |
AI Opinion
Fundamentals
FY25 earnings call signals inflection: 12% revenue growth, 3x Adj. EBITDA, and strong cash flow ($47M OCF) driven by operating leverage and cost discipline. FY26 guidance projects 12% revenue and 45% Adj. EBITDA growth, with margin expansion and robust RPO ($335M) supporting visibility. U.S. market traction and share buybacks reinforce confidence, but persistent historical profitability volatility and rising SG&A remain risks. Execution on margin and U.S. expansion is critical.
Peer Comparison
Despite apparent undervaluation (fair value $17.28 vs $9.41), CGNT ranks bottom-tier on profitability vs peers (negative ROE, net margin, and operating margin). High gross margin but severe operational inefficiency. Recent improvements must prove durable before peer discount narrows.
Macro Environment
Macro tailwinds: sector at YTD highs, tech leadership, and easing rates (Fed Funds -1% YoY) support demand. Stable inflation (2.3%) and expansionary indicators offset by weak consumer sentiment and slight unemployment uptick. CGNT's government/enterprise focus is less cyclical, but U.S. budget risk and global policy uncertainty remain. Earnings call confirms strong demand and execution, especially in U.S. market.
Key Metrics
Gross margin 71%, FY25 revenue +12%, Adj. EBITDA +3x YoY, OCF $47M, cash $113M, no debt, negative ROE (-6.1%), net margin -3.4%, SG&A rising. FY26 guidance: revenue $392M (+12%), Adj. EBITDA $43M (+45%), non-GAAP EPS $0.16.
Insider Activity
No significant insider activity in the past 30 days
Income Statement
Revenue growth accelerating (12% YoY), gross margin high (71%), but historical operating and net margins negative. FY25 saw significant profitability improvement (Adj. EBITDA $29M, +114% YoY in Q4), with FY26 guidance for further margin expansion and positive non-GAAP EPS ($0.16). SG&A cost creep is a watch item.
Cash Flow
OCF swung from -$37M (2023) to $47M (FY25), FCF positive and improving. FY26 OCF guided to $45M (slightly lower due to exceptional FY25 collections). Working capital and collection efficiency are recent strengths, but sustainability needs monitoring.
Balance Sheet
Very strong: $113M cash, no debt, negative net debt, and rising equity base. Deferred revenue robust ($130M). High financial flexibility and no dilution risk. Deferred tax liabilities rising, requiring monitoring.